TORONTO, May 22 /CNW/ - DELISTING REVIEW - Response Biomedical Corp. (the
"Company") - Further to TSX Bulletin 2009-0577 dated May 7, 2009, TSX has
completed its review of the common shares of the Company (Symbol: RBM) and has
determined that it meets TSX's continued listing requirements.
About TMX Group (TSX-X)
TMX Group's key subsidiaries operate cash and derivative markets for
multiple asset classes including equities, fixed income and energy. Toronto
Stock Exchange, TSX Venture Exchange, Montreal Exchange, Natural Gas Exchange,
Boston Options Exchange (BOX), Shorcan, Equicom and other TMX Group companies
provide trading markets, clearing facilities, data products and other services
to the global financial community. TMX Group is headquartered in Toronto with
offices in Montreal, Calgary and Vancouver. For more information about TMX
Group, visit our website at www.tsx.com.
For further information:
For further information: Corporate Communications, TMX Group Inc., Toll
Free 1-888-873-8392, firstname.lastname@example.org.